Applying flow cytometry, immunoblotting, tumor killing and ELISpot assays, we identified TNF and IL-1β to be the strongest inducers of MHC-I, and partly ICAM-1 and CD83 on the majority of pediatric sarcoma cell lines tested. Here, CD83 is linked to neoplasm.